2nd Sep 2020 7:00 am |
RNS |
Notice of Half Year Results |
18th Aug 2020 7:00 am |
RNS |
Expansion of CARMA’s Phase I Trial of MCY-M11 |
14th Aug 2020 7:00 am |
RNS |
Holding(s) in Company |
16th Jul 2020 6:04 pm |
RNS |
Director Dealings and Issue of Equity |
15th Jul 2020 7:00 am |
RNS |
Trading Update |
8th Jul 2020 7:00 am |
RNS |
APEIRON Biologics Clinical and Commercial License |
1st Jul 2020 7:00 am |
RNS |
Block Listing Return & TVR |
2nd Jun 2020 5:54 pm |
RNS |
Holding(s) in Company |
28th May 2020 3:34 pm |
RNS |
Holding(s) in Company |
26th May 2020 5:49 pm |
RNS |
Holding(s) in Company |
26th May 2020 4:22 pm |
RNS |
Holding(s) in Company |
26th May 2020 3:45 pm |
RNS |
Holdings in Company |
21st May 2020 1:50 pm |
RNS |
Result of Special Meeting and Issue of Equity |
14th May 2020 7:00 am |
RNS |
Poster Presentation on MCY-M11 at ASCO 2020 |
7th May 2020 7:00 am |
RNS |
License Agreement with Caribou Biosciences |
1st May 2020 7:00 am |
RNS |
Result of Offering |
30th Apr 2020 5:39 pm |
RNS |
Proposed Offering to raise up to £25.1 million |
21st Apr 2020 7:00 am |
RNS |
Final Results for Year Ended 31 December 2019 |
9th Apr 2020 7:00 am |
RNS |
Business Update Related to COVID-19 Pandemic |
24th Mar 2020 7:00 am |
RNS |
License Agreement with Allogene Therapeutics |
21st Feb 2020 7:00 am |
RNS |
Consolidation of Trading Lines |
20th Feb 2020 6:18 pm |
RNS |
AIM Block Admission Return / Total Voting Rights |
5th Feb 2020 7:00 am |
RNS |
MaxCyte to Present at BIO CEO & Investor Conf |
24th Jan 2020 4:31 pm |
RNS |
Grant Of Options |
22nd Jan 2020 5:15 pm |
RNS |
Holding(s) in Company |
22nd Jan 2020 5:11 pm |
RNS |
Holding(s) in Company |
22nd Jan 2020 5:08 pm |
RNS |
Holding(s) in Company |
20th Jan 2020 7:00 am |
RNS |
Trading Update |
19th Dec 2019 7:00 am |
RNS |
New Executive Vice President and Trial Update |
16th Dec 2019 5:25 pm |
RNS |
Director/PCA transaction initial notification |
4th Dec 2019 7:00 am |
RNS |
Agreement with KSQ Therapeutics |
21st Nov 2019 7:00 am |
RNS |
Vor Biopharma Clinical and Commercial License |
14th Nov 2019 7:00 am |
RNS |
Presentation at Jefferies Healthcare Conference |
7th Nov 2019 7:00 am |
RNS |
MaxCyte to Present at BIO-Europe 2019 |
1st Nov 2019 1:04 pm |
RNS |
Result of AGM |
24th Oct 2019 7:00 am |
RNS |
MaxCyte Advances Phase I Clinical Trial |
23rd Oct 2019 7:01 am |
RNS |
Presentations at Cell & Gene Therapy Congress |
8th Oct 2019 7:00 am |
RNS |
Notification of AGM and Audit Declaration |
7th Oct 2019 7:00 am |
RNS |
Editas Clinical and Commercial License Agreement |
30th Sep 2019 7:00 am |
RNS |
Updates on CARMA Platform at Upcoming Meetings |